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Helicobacter pylori is a widespread human pathogen
that can cause gastric ulcers and cancer. To identify
surface proteins that may play a role in pathogen-host
interactions and represent potential targets for the con-
trol of this infection, we selectively biotinylated intact
H. pylori with the hydrophilic reagent sulfosuccinimi-
dyl-6-(biotinamido)-hexanoate and purified the labeled
proteins by membrane isolation, solubilization, and af-
finity chromatography. After separation of 82 biotiny-
lated proteins on two-dimensional gels, 18 were identi-
fied with comparison to proteome data and peptide
mass fingerprinting. Among the identified proteins, 9
have previously been shown to be surface-exposed, 7 are
associated with virulence, and 11 are highly immuno-
genic in infected patients. In conclusion, this generally
applicable combined proteome approach facilitates the
rapid identification of promising targets for the control
of H. pylori and might be applicable to numerous other
human pathogens although larger biotinylation re-
agents might be required in some cases to prevent per-
meation of porin channels in the outer membrane.
Helicobacter pylori is a micro-aerophilic, Gram-negative bac-
terium that colonizes in the stomach of 50% of the world
human population (1, 2). Infection results in chronic inflamma-
tion of the gastric mucosa, which in most cases remains asymp-
tomatic. However, in 10% of those infected severe pathological
consequences develop including gastric and duodenal ulcer,
atrophic gastritis, adenocarcinoma, or mucosa-associated
lymphoid tissue (MALT) lymphoma.
The surface of H. pylori provides an important interface for
pathogen-host interactions including flagella-driven motility in
the stomach mucus layer, local buffering of stomach acid by
urease, adhesion to gastric epithelial cells mediated by several
adhesins including BabA (3), AlpA/AlpB (4), HopZ (5), translo-
cation of CagA into host cells via the type IV secretion appa-
ratus encoded in the Cag1 (cytotoxin-associated genes) patho-
genicity island (6–10), and adherence of neutrophils to
endothelial cells induced by the neutrophil-activating protein
(NAP) (11). Envelope proteins are particularly accessible to
host immune responses and to drug therapy and thus could be
used to control this important human pathogen. Because of its
outstanding importance, several approaches have been devel-
oped to identify and characterize additional H. pylori envelope
proteins.
Global theoretical predictions of outer membrane proteins
based on the two completely sequenced genomes and physico-
chemical properties and sequence similarities to proteins with
known surface localization have yielded 64 putative candidates
(12). Several of these have been experimentally verified, but it
is unclear if all of the predicted surface proteins are expressed.
Moreover, several proposed surface proteins including urease,
Hsp60, Hsp70, flagellar sheath protein, and catalase do not
share common properties of surface proteins and are therefore
neglected by theoretical predictions.
Surface proteins including outer membrane proteins can be
experimentally identified by selective solubilization and su-
crose gradient centrifugation for enrichment of outer mem-
brane fractions. In H. pylori, these techniques yielded enriched
outer membrane fractions, and many putative surface proteins
have been found. However, these preparations are heavily con-
taminated by inner membrane components (13, 14), so that
independent evidence, such as specific antibody binding to
intact bacteria, is necessary to verify true surface proteins (15).
Five outer membrane proteins with the typical -barrel struc-
ture were identified by their anomalous temperature-depend-
ent migration in polyacrylamide gels (14), but surface proteins
with different structures escaped this method.
Selective labeling with reactive reagents is an alternative
approach to identify surface proteins. In H. pylori urease could
be labeled with 125I demonstrating its surface localization (16).
Labeling with a reactive sugar ligand confirmed the specific
binding of the Lewisb antigen to the surface-exposed H. pylori
adhesin BabA (3). The hydrophilic reagent S-NHS-LC-biotin
(sulfosuccinimidyl-6-(biotinamido)hexanoate) allowed us to se-
lectively biotinylate surface proteins of Escherichia coli al-
though to a lesser extent periplasmic proteins were also labeled
(17). Here, we confirmed the periplasmic labeling for the well
characterized MalE protein of E. coli and showed that lysis
followed by membrane purification removes all of the labeled
MalE protein. We then applied this technique to identify sur-
face proteins of H. pylori. Biotinylated membrane proteins of H.
pylori were further enriched by avidin-affinity chromatogra-
phy, separated by two-dimensional gel electrophoresis, and
identified by peptide mass fingerprinting. This generally appli-
cable approach led to the rapid experimental identification of
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both new and previously known H. pylori envelope and puta-
tive surface proteins.
EXPERIMENTAL PROCEDURES
E. coli HB2151 was grown in M9 minimal medium supplemented
with 0.2% maltose, to induce the mal operon (18), 0.1% hydrolysated
casein, and 1 M biotin to block active uptake of the biotinylation
reagent. The cells were harvested at an OD600 nm of 0.6–0.7, corre-
sponding to the mid-exponential growth phase.
H. pylori strain 26695 (19) was cultured at 37 °C in a micro-aerobic
atmosphere (5% O2, 85% N2, and 10% CO2) on serum-agar plates (20)
for 3 days, and grown for 1 additional day on fresh plates. The bacteria
were harvested and suspended in ice-cold phosphate-buffered saline, 1
mM CaCl2, 0.5 mM MgCl2, 1.6 mM biotin at an OD600 nm of 2.5–3.5
(equivalent to 1–2  109 colony-forming units). The bacteria were
surface-labeled by incubation with 200 M (final concentration) S-NHS-
LC-biotin (Pierce) for 30 min on ice. The reaction was stopped by adding
two volumes of TNKCM (50 mM Tris, pH 7.4, 100 mM NaCl, 27 mM KCl,
1 mM CaCl2, 0.5 mM MgCl2). After 10 min of incubation at room tem-
perature, the bacteria were sedimented by centrifugation at 3,500  g
for 10 min and washed three times with TNKCM.
The viability of the bacteria before and after labeling was determined
by plating on serum-agar and by flow cytometry as well as fluorescence
microscopy using a membrane-permeable (Syto9) and a membrane-
impermeable (propidium iodide) fluorophore according to the manufac-
turer’s instructions (LIVE/DEAD kit, Molecular Probes) except that an
altered ratio in millimolar of 3:27 of the dyes Syto9/propidium iodide
was used.
To isolate biotinylated membrane proteins, labeled bacteria were
resuspended in 50 mM Tris-HCl, pH 7.4, 1 mM MgCl2 with protease
inhibitors (0.5 mM phenylmethylsulfonyl fluoride, 1 M pepstatin, 1 M
leupeptin, 2.9 mM benzamidin) and disrupted by 4 passages through a
French press at 15,000 lb/in2. After removal of intact bacteria by two
centrifugations at 4,000  g and 4 °C for 10 min, membranes were
pelleted at 40,000  g and 4 °C for 30 min and then washed, and
resuspended in TKE (50 mM Tris-HCl, 150 mM KCl, 10 mM EDTA,
protease inhibitors, pH 7.4). Membranes were adjusted to a protein
concentration of 5 mg/ml, solubilized with 2% zwittergent 3-14 (Fluka),
and incubated for 1 h at 4 °C with head-over-head mixing. Insoluble
membranes were removed by ultracentrifugation for 1 h at 100,000  g
and 4 °C. The soluble fraction was purified by affinity chromatography
on reversibly binding avidin-agarose according to the instructions of the
manufacturer (Roche Molecular Biochemicals) with slight modifica-
tions. In brief, 20–24 mg of membrane proteins were diluted 10-fold in
100 mM NaPO4, 150 mM NaCl, pH 7.2 and mixed with 1 ml of avidin-
agarose matrix equilibrated in washing buffer (100 mM NaPO4, 150 mM
NaCl, pH 7.2, 0.2% zwittergent). After 30 min of incubation at room
temperature, the matrix was washed five times with 2 ml of washing
buffer. The biotinylated proteins were eluted by rising the avidin-
agarose five times for 15 min at 37 °C with washing buffer containing 5
mM D-biotin. Protein-containing fractions were pooled and concentrated
by acetone precipitation.
One dimensional SDS-PAGE and blotting on polyvinylidene difluo-
ride membranes were performed according to standard protocols. Bio-
tinylated proteins were detected on the blots using neutravidin-
peroxidase staining (Pierce) and chemiluminescent visualization (ECL,
Amersham Biosciences) according to the manufacturer’s instructions.
The maltose-binding protein MalE was detected with a monoclonal
antibody (Sigma) and a polyclonal anti-mouse IgG-horseradish peroxi-
dase conjugate (Nordic).
Two-dimensional gel electrophoresis and protein identification by
MALDI-MS were performed as described previously (21). In brief, pro-
tein samples were solubilized for 30 min at ambient temperature in 9 M
urea, 1% CHAPS, 70 mM dithiothreitol, 2% Servalyte pI 2–4 (Serva).
For the resolution of protein samples a 23  30 cm two-dimensional gel
electrophoresis system was used. For the identification of proteins
200–300 g (total cell samples) or 50–70 g (biotinylated proteins)
were applied to the anodic side of the IEF gel. Proteins were identified
by peptide mass fingerprinting after in-gel tryptic digestion of excised
spots. The peptide mixture was mixed (1:1) with a saturated -cyano-
4-hydroxycinnamic acid solution in 50% acetonitrile, 0.3% trifluoroace-
tic acid, and 2 l were applied to the sample template of a MALDI mass
spectrometer (Voyager Elite, Perseptive). Peptide mass fingerprints
were searched with the program MS-FIT (prospector.ucsf.edu/ucsfhtml/
msfit.htm) using all H. pylori proteins in the NCBI data base allowing
a mass accuracy of 100 ppm for the peptide masses. Partial enzymatic
cleavages leaving two cleavage sites, oxidation of methionine, pyroglu-
tamic acid formation at the N-terminal glutamine, and modification of
cysteine by acrylamide were considered in these searches.
RESULTS
Surface proteins may mediate important pathogen-host in-
teractions in H. pylori infections. To identify novel Helicobacter
surface proteins, we adapted a method that had been originally
developed for E. coli (17). In this method, bacteria are treated
with the hydrophilic biotinylation reagent S-NHS-LC-biotin
that cannot permeate lipid bilayers. As a result of its limited
access, this compound reacts preferentially with free amino
groups of surface proteins. However, some of the reagent obvi-
ously enters the periplasm possibly through water-filled chan-
nels of E. coli outer membrane porins, resulting in substantial
labeling of periplasmic proteins, which potentially confuses the
localization of previously uncharacterized proteins.
To confirm these studies, we labeled E. coli lysate and intact
cells, separated the samples by two-dimensional gel electro-
phoresis, and detected incorporated biotin by neutravidin
staining (data not shown). Almost all proteins of the labeled
lysate were biotinylated suggesting that most E. coli proteins
contain accessible free amino groups. In contrast, labeling of
intact bacteria resulted in a small subset of biotinylated puta-
tive surface proteins. However, MalE, which is a well charac-
terized periplasmic protein and can be detected with a com-
mercial monoclonal antibody, was also heavily labeled.
We first tried to enhance the labeling selectivity by lowering
the reagent concentration. A 5-fold lower amount (200 M)
compared with the original procedure still gave sufficiently
strong biotinylation, but this did not prevent biotinylation of
MalE. We then tried to increase selectivity by using a larger
biotinylation reagent. As periplasmic labeling appears to be the
result of permeation of the reagent through porin channels,
enlargement of the reagent might prevent access to the
periplasm resulting in higher selectivity. We increased the
molecular weight by coupling sulfo-succinimidyl-6-[3-(2-pyri-
dyldithio)-propionamido]hexanoate via its sulfhydryl group
to ()-biotinyl-3-maleimidoproprionamidyl-3,6-dioxaoctane-
diamine. The resulting biotinylation compound has a calcu-
lated molecular mass of 943 Da, which exceeds the exclusion
limit of reported porin channels ( 600 Da, OmpF in E. coli,
Refs. 22 and 23); 800 Da, Salmonella typhimurium, Ref. 24).
Indeed, this compound substantially reduced the relative bioti-
nylation of MalE in comparison with other protein species, but
the remaining MalE labeling was still not acceptable (data not
shown). As the reagent was difficult to generate we discontin-
ued its use.
As the various attempts to enhance selectivity were only
partially successful, we decided to remove the contaminating
periplasmic biotin-labeled proteins by cell lysis followed by
membrane sedimentation. After this simple membrane enrich-
ment, there remained no detectable MalE protein suggesting
that the periplasmatic proteins were indeed efficiently removed
(Fig. 1). Accordingly, the remaining biotinylated proteins most
likely represent true surface proteins (see “Discussion”).
We then applied this modified procedure to H. pylori. In
contrast to E. coli, this organism is especially prone to autolysis
in vitro (25, 26), which could prevent interpretable results. To
test if such unwanted lysis occurred during labeling, the via-
bility of the bacteria was determined before and after labeling
by plating, fluorescence microscopy, and flow cytometric anal-
ysis using a combination of membrane-permeable and non-
permeable fluorescent dyes (LIVE/DEAD staining). Plating in-
dicated that less than 10% of the bacteria were killed during
incubation and washing. Moreover, only 2–5% of the bacteria
had a compromised membrane integrity after labeling as de-
termined by LIVE/DEAD staining. The small portion of killed














bacteria might have released some cytosolic material but most
of this would be removed during subsequent washing steps.
Therefore cytosolic components are not likely to contaminate
the labeled proteins.
In H. pylori, unlabeled samples contained only one weakly
avidin-binding spot (apparent molecular mass of about 20 kDa,
pI 9.0; data not shown) as shown by two-dimensional electro-
phoresis, blotting, and avidin-peroxidase conjugate staining.
When H. pylori lysates were labeled, almost all proteins that
could be detected by staining with Coomassie Blue were also
biotinylated, indicating that almost all proteins possess acces-
sible amino groups (Fig. 2). Among the very few proteins that
did not bind avidin, there were the previously identified citrate
synthase and NapA (21). In addition, Hsp60 and the urease
-subunit were present in high amounts but gave compara-
tively weak signals in the neutravidin-peroxidase staining
compared with other less abundant spots. This is surprising
because Hsp60, NapA, and urease -subunit contain many
lysine residues. Possibly, these lysines are not readily accessi-
ble to the biotinylation reagent.
In contrast to the almost complete labeling of lysate proteins,
labeled intact H. pylori contained only 102 spots that were
reproducibly biotinylated and resolved in three independent
experiments (Fig. 3). Several species appeared as horizontal
spot series instead of single spots, and such spot series might
represent different modifications of a single protein species (see
below). Taking this into account, 34 distinct protein species
were resolved. Most species had isoelectric points in the alka-
line range. A comparison of labeled intact cells versus labeled
lysates (Figs. 2 and 3) revealed a high selectivity of biotinyla-
tion as expected for a hydrophilic reagent and intact mem-
branes. In contrast, the uncharged sulfhydryl-reactive reagent
polyethylene oxide-iodoacetyl biotin labeled several known cy-
toplasmic proteins, indicating permeation of the bacterial
membranes.
Based on our experience with labeled periplasmic proteins in
E. coli that can be effectively removed by membrane isolation
(see above), we enriched putative biotinylated Helicobacter sur-
face proteins by lysis and membrane sedimentation. Surpris-
ingly, in the case of Helicobacter this did not result in a major
change in the two-dimensional electrophoretic pattern of bio-
tinylated proteins, and all spots were preserved suggesting
that few if any periplasmic proteins had been labeled. One
possible explanation could be that H. pylori strain 26695 may
lack large porin channels through which the biotinylation rea-
gent can get access to the periplasm (see “Discussion”). Addi-
tional studies are required to clarify this issue.
To further enrich the biotinylated proteins, they were solu-
bilized with zwittergent 3-14 and applied to a reversible biotin-
binding avidin D column and washed and eluted with biotin.
Two-dimensional electrophoresis of these purified labeled pro-
teins revealed 162 spots corresponding to 59 different species
(see above) as detected by silver staining (Fig. 4a) most of
which (53 of 59, i.e. 90%) were biotinylated (Fig. 4b). The
remaining 6 species were considered minor contaminants of
non-biotinylated proteins as indicated by their weak silver
staining. Moreover, 76 additional spots corresponding to 29
FIG. 1. One-dimensional blot of biotinylated intact E. coli cells.
A, neutravidin staining. B, anti-MalE staining. Lane 1, complete E. coli
cells; lane 2, membrane fraction. The arrow indicates the MalE protein.
FIG. 2. Two-dimensional blot of biotinylated H. pylori lysates
stained with neutravidin-coupled peroxidase. In contrast to Figs.
3 and 4, a small gel (8  7 cm) was used for this control experiment.
FIG. 3. Two-dimensional blot of biotinylated intact H. pylori
cells stained with neutravidin-coupled peroxidase. Marked spots
were identified. Numbers correspond to the numbers in Table 1. The
original gel size was 23  30 cm.














different species appeared in the neutravidin-peroxidase stain-
ing but were not visualized by silver staining probably due to
their low amount. Compared with whole biotinylated H. pylori,
the overall avidin binding patterns of purified proteins were
quite similar but more complex and difficult to assign because
of longer spot series and more total detectable species (48 spots
in addition). Possibly, these additional species escaped detec-
tion in non-enriched whole cell samples because of low abun-
dance. In contrast, all but 2 of 34 biotinylated proteins from
whole H. pylori could also be detected in the enriched protein
fraction.
To tentatively identify the biotinylated proteins, we com-
pared the avidin binding patterns with the H. pylori strain
26695 reference pattern in our data base (www.mpiib-berlin.
mpg.de/2D-PAGE, Ref. 21). The relative positions of 18 bio-
tinylated species matched with previously identified Heli-
cobacter proteins (Table I). To confirm these tentative assign-
ments, the 13 most abundant biotinylated species were cut out
from the blots, digested, and identified by peptide mass finger-
printing. All of the direct identifications were consistent with
the indirect assignments, which confirmed the validity of the
indirect approach. For 8 of 13 proteins, tryptic peptide masses
that fit theoretical masses covered more than 30% of the cor-
responding protein sequence. This allowed confident identifi-
cation. For spots 6 and 10, sequence coverage was lower but all
major mass peaks matched with HP1118 and HP1098, respec-
tively. All 10 assignments and 2 additional proteins with weak
sequence coverage (HP0231, HP0659) verified the previous
identification based on comparison to the standard proteome
pattern, suggesting the validity of this indirect approach.
Most unlabeled proteins of H. pylori appear as single spots in
the two-dimensional pattern. In contrast, most labeled protein
species appeared as horizontal spot series, which could repre-
sent the same protein with slight modifications that alter the
pI. This was confirmed for three members of a biotinylated spot
series corresponding to catalase (data not shown). Probably, a
variable number of amino groups reacted with the biotinylation
reagent resulting in a differential loss of protonable residues
and stepwise decreasing pI values. The pI difference between
consecutive members of spot series were largely constant and
in the range of one protonable group per molecule (pI of
0.05), which is consistent with this hypothesis. Using a 25-
fold greater amount of biotinylation reagent, many extensive
spot series were obtained (data not shown). Moreover, acidic
members of spot series were enriched during the avidin-affinity
chromatography, which further enriches for highly biotinylated
species.
DISCUSSION
Surface proteins of H. pylori mediate important pathogen-
host interactions that are essential for colonization, adherence,
survival, and virulence of this pathogen. To identify H. pylori
surface proteins, several approaches have been used (see the
Introduction). Using a global proteome approach, we combined
a selective biotinylation of free amino groups with membrane
isolation followed by affinity purification of solubilized pro-
teins, two-dimensional electrophoresis, and peptide mass
fingerprinting.
A prerequisite for this method is the presence of free amino
groups that are exposed to the external medium. The genome
sequences indicate that except for two predicted proteins all
contain one or several lysine residues.2 Many of these residues
2 D. Frishman, personal communication.
FIG. 4. Two-dimensional blot of biotinylated membrane proteins purified from labeled intact H. pylori cells. A, silver staining; B,
neutravidin staining. The original gel size was 23  30 cm.














seem to be on the outside of the corresponding protein struc-
tures, because almost all detectable protein species in H. pylori
lysates can be labeled using the hydrophilic biotinylation rea-
gent S-NHS-LC-biotin that reacts with free amino groups. In
contrast, in intact bacteria only a subset of the proteome was
labeled, indicating that the hydrophobic membranes limited
the accessibility of most proteins for the highly hydrophilic
biotinylation reagent. While the inner membrane is essentially
impermeable for the reagent, previous studies (17), which we
confirmed in this study, have shown that in E. coli, the outer
membrane is partially permeable for S-NHS-LC-biotin, result-
ing in substantial labeling of periplasmic proteins. Outer mem-
brane porins contain water-filled channels that permit the
diffusion of hydrophilic molecules with molecular masses up to
800 Da (24, 27), which is well above the molecular mass of
S-NHS-LC-biotin (560 Da). If porins are indeed the cause of
periplasm access, enlargement of the biotinylation reagent
above the exclusion limit could improve its selectivity for sur-
TABLE I
Surface-exposed proteins of H. pylori
a Sequence coverage of matching peptides in tryptic peptide mass fingerprints; c, identified by comparison with the standard proteome pattern.
b sur, surface; sec, secreted; per, periplasm; homologue, paralogue or orthologue in other organisms.
c Strongly recognized by sera from infected patients according to combined data from three studies (Refs. 41, 50, 51).
d nd, not determined.
e Footnote 3.














face proteins. We synthesized a reagent with a calculated mo-
lecular mass of 943 Da, which showed increased but still not
sufficient selectivity in a well defined E. coli model system.
This result suggests that still larger reagents might be highly
specific but because of the absence of commercially available
suitable precursors we could not follow this approach. Instead,
we observed that following the reaction with S-NHS-LC-biotin,
unwanted periplasmic-labeled proteins could be completely re-
moved by cell lysis with a simple membrane sedimentation.
When applied to H. pylori, this approach showed that only a
few minor biotinylated spots were lost during membrane en-
richment, suggesting that the outer membrane of H. pylori may
possibly be less leaky for S-NHS-LC-biotin when compared
with the outer membrane of E. coli. Indeed, single-channel
conductance measurements have suggested smaller pore sizes
for the H. pylori porins HopA, HopB, HopC, HopD (14), HopE
(29), and HopV (30) compared with E. coli OmpF with a size
exclusion limit of 600 Da. In contrast, Helicobacter HopX might
have a larger pore, but this porin is apparently not expressed in
detectable quantities (30).
The absence of large porin channels that permit permeation
of the S-NHS-LC-biotin in H. pylori is also supported by the
fact that the great majority of identified biotinylated proteins
are likely to be true H. pylori surface proteins based on evi-
dence obtained with independent methods (see below), which
suggests that the labeling was indeed highly selective for sur-
face proteins.
In total, 82 putative surface-exposed H. pylori protein spe-
cies were found by selective labeling and membrane isolation,
and 18 of these were identified. It is likely that H. pylori
possesses some additional surface proteins that escaped label-
ing. Three prominent proteins (UreB, NapA, Hsp60) were only
weakly labeled in lysates, indicating that their localization
could not be assessed using this approach, although their sur-
face localization has previously been demonstrated (31, 32, 55).
Among the 18 identified proteins, several have been already
predicted to be surface-exposed in H. pylori based on results
from various independent methods. Antibody staining indi-
cated that urease A, catalase, and a homologue of HP0410, the
flagellar sheath protein, are on the surface (25, 31, 33, 34).
MsrA, the cell-binding factor 2, HP0231, HP1098, HP1350,
HtrA, carbonic anhydrase, and -glutamyltranspeptidase have
been found to be secreted into the extracellular medium (35,
36). The large overlap between surface-exposed, firmly bound
proteins (this study) and previously characterized secreted pro-
teins is consistent with the concept of re-adsorption of released
proteins at the H. pylori surface in vitro (25, 26). HefA is
homologous to TolC, an outer membrane protein from E. coli
(37, 38), while HP1564 is homologous to an outer membrane
protein of Pasteurella hemolytica (39). In contrast, the ABC
transporter of iron, CeuE, is likely to be localized in the
periplasm based on data from E. coli (40). However, a subpopu-
lation of this protein might still be surface-exposed like other
classic periplasmic proteins that have been found in this and
previous studies to be surface-exposed in H. pylori (HtrA, -glu-
tamyltranspeptidase). In summary, the various evidence
strongly supports that our methods almost exclusively identi-
fies surface proteins, although independent evidence would
still be needed for the several candidates that have not been
previously characterized.
Interestingly, only 2 of 18 identified proteins (HP0605,
HP1564) have been theoretically predicted to be surface pro-
teins, and none of the hypothetical outer membrane proteins
(HOPs) have yet been found. The strain HP26695 is known
neither to express BabA nor several members of the HOP
family (3, 5). HopC has been reported to be expressed in this
strain (41) and might be among the yet unidentified labeled
protein species.
Several surface proteins of H. pylori mediate important host-
pathogen interactions. This is also the case for some of the 18
proteins that were identified in this study. Two of them have
been previously described as essential virulence factors (ure-
ase, -glutamyltranspeptidase). Moreover, the flagellar sheath
protein is part of functional flagella that are also essential for
virulence. Cag16 is a member of the Cag pathogenicity island
that is known to enhance inflammatory responses to H. pylori.
Cag16 is essential for the expression of the VirB7 homologue
HP0532, which is supposedly a structural component of the
type IV secretion system (42, 43). The HP1098 paralogue HcpA
induces IL-12-dependent IFN- secretion in CD4/NK cells
(44). For other human pathogens, homologues of catalase (e.g.
in Legionella, Ref. 45, Mycobacterium, Ref. 46, or Campy-
lobacter, Ref. 47) and the protease HtrA (in Salmonella, Bru-
cella, and Yersinia, Ref. 48) are important for virulence. Indeed
all fresh human isolates of H. pylori express catalase, which is
apparently essential for survival of the phagocyte oxidative
burst in cell culture models (49). Information about a potential
role for HtrA in H. pylori virulence is lacking. It would be
interesting to functionally characterize HtrA and, in particu-
lar, the additional surface proteins with no known homologues
in other organisms.
Surface proteins of H. pylori are particularly exposed to the
host immune system and therefore might represent major an-
tigens. Indeed, 11 of 18 identified proteins are among the
previously described 32 antigens that are recognized by a ma-
jority of sera from infected humans (41, 50, 51). This indicates
that our identification procedure strongly enriched for highly
immunogenic antigens (11 antigens of 18 surface proteins ver-
sus 32 antigens of 1560 total proteins). This set of proteins
therefore represents a basis to rationally select antigen candi-
dates for vaccine development. Indeed, 2 of 18 identified pro-
teins (catalase, urease) have previously been shown to induce
protective immunity against a H. pylori challenge infection in
the mouse model. We have recently shown that HP0231 and
HP0410 are also highly protective in the mouse Helicobacter
infection model.3 Additional candidate antigens are currently
being tested.
In conclusion, a rapid proteome approach has been developed
to identify surface proteins of H. pylori that are promising
targets for the control of this important human pathogen.
When larger biotinylation reagents become available, this ap-
proach should be generally applicable to characterize the sur-
face of pathogens to identify new potential target proteins for
drug therapy and vaccine development.
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